LoginRegister
    Tech firms tackle opioid crisis with softwareTech firms tackle opioid crisis with software
    Setback: Delhi HC restricts Natco Pharma from manufacturing cancer drug CeritinibSetback: Delhi HC restricts Natco Pharma from manufacturing cancer drug Ceritinib
    Fortis Healthcare International to sell entire stake in MSCLFortis Healthcare International to sell entire stake in MSCL
    Pfizer gets USFDA approval for Fragmin to treat blood clot in pediatric patientsPfizer gets USFDA approval for Fragmin to treat blood clot in pediatric patients
    Jubilant Life Sciences posts net loss of Rs 100.65 crore in Q4Jubilant Life Sciences posts net loss of Rs 100.65 crore in Q4
    Hikma Pharma backs annual outlook boosted by medicine demandHikma Pharma backs annual outlook boosted by medicine demand
    Met Museum: No more money from family connected to OxyContinMet Museum: No more money from family connected to OxyContin
    Democrats push bill on health care, drug prices through HouseDemocrats push bill on health care, drug prices through House
    CDSCO releases Risk classification of newly notified Medical Devices, IVDs; DetailsCDSCO releases Risk classification of newly notified Medical Devices, IVDs; Details
    Aurobindo Pharma: USFDA designates 3 facilities as Official Action IndicatedAurobindo Pharma: USFDA designates 3 facilities as 'Official Action Indicated'
    Cipla gets no USFDA observations for Indore facilityCipla gets no USFDA observations for Indore facility
    Pfizer Abrocitinib to treat atopic dermatitis meet goals in late-stage studyPfizer Abrocitinib to treat atopic dermatitis meet goals in late-stage study
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X